VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 11 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $36,165,000 | -8.2% | 1,795,700 | +19.9% | 0.04% | -20.0% |
| Q1 2016 | $39,392,000 | -44.9% | 1,497,800 | +112.8% | 0.05% | -35.9% |
| Q4 2015 | $71,541,000 | +21.8% | 703,800 | +113.7% | 0.08% | +39.3% |
| Q3 2015 | $58,758,000 | +67.1% | 329,400 | +108.1% | 0.06% | +86.7% |
| Q2 2015 | $35,166,000 | +10.4% | 158,300 | -1.2% | 0.03% | 0.0% |
| Q1 2015 | $31,839,000 | +32.8% | 160,300 | -4.3% | 0.03% | +25.0% |
| Q4 2014 | $23,971,000 | +0.4% | 167,500 | -8.0% | 0.02% | -4.0% |
| Q3 2014 | $23,878,000 | -17.8% | 182,000 | -21.0% | 0.02% | -24.2% |
| Q2 2014 | $29,045,000 | +38.0% | 230,300 | +44.2% | 0.03% | +32.0% |
| Q1 2014 | $21,053,000 | +17.0% | 159,700 | +4.2% | 0.02% | +8.7% |
| Q4 2013 | $17,997,000 | +21.3% | 153,300 | +7.8% | 0.02% | 0.0% |
| Q3 2013 | $14,836,000 | +31.6% | 142,200 | +8.5% | 0.02% | +21.1% |
| Q2 2013 | $11,276,000 | – | 131,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,425 | $12,266,000 | 0.82% |
| GROUP ONE TRADING, L.P. | 127,400 | $10,967,000 | 0.27% |
| KNIGHT CAPITAL GROUP LLC | 23,200 | $1,997,000 | 0.04% |
| Timber Hill LLC | 92,700 | $7,980,000 | 0.03% |
| Citadel Advisors | 131,000 | $11,276,000 | 0.02% |